Progesterone Vaginal Insert
NDC Package 70700-201-70
Package Information
Progesterone Vaginal Insert (progesterone) inserts is progesterone vaginal insert is indicated, as part of an Assisted Reproductive Technology (ART) treatment program, to support embryo implantation in infertile women less than 35 years of age by supplementation of corpus luteal function and to maintain pregnancy after implantation up to 10 weeks. This formulation utilizes a insert delivery system. Marketed by Xiromed, Llc, this product is identified by NDC 70700-201 and is authorized under FDA application ANDA218391.
Identification & Billing
- RxCUI: 725094 - progesterone 100 MG Vaginal Tablet
- RxCUI: 725094 - progesterone 100 MG Vaginal Insert
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70700 - Xiromed, Llc
- 70700-201 - Progesterone Vaginal Insert
- 70700-201-70 - 1 CARTON in 1 CARTON / 21 BLISTER PACK in 1 CARTON (70700-201-69) / 1 INSERT in 1 BLISTER PACK (70700-201-68)
- 70700-201 - Progesterone Vaginal Insert
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70700-201-70 identifies a specific commercial package of 1 carton in 1 carton / 21 blister pack in 1 carton (70700-201-69) / 1 insert in 1 blister pack (70700-201-68) of Progesterone Vaginal Insert, a human prescription drug labeled by Xiromed, Llc. This insert is formulated for vaginal use and contains progesterone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xiromed, Llc on September 23, 2025. The current certification is valid through December 31, 2027.
How is this Xiromed, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70700020170. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 21 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.